Observational study of blood transfusions in European preterm infants
International Neonatal tranSfusion PoInt pREvalence study
- Registry ID
- ISRCTN17267090
- Source registry
- ISRCTN
- Status
- No longer recruiting
- Study type
- OBSERVATIONAL
- Sponsor
- Leiden University Medical Center
- Enrollment
- 520
- Start date
- 2022-09-26
- Completion date
- 2023-09-30
- Last update
- 2026-08-17
Conditions
Summary
The use of blood transfusion in European preterm infants
Detailed description
In this international, multicenter, prospective, observational point prevalence study, the researchers will include neonates with gestational age at birth <32 weeks admitted to a participating tertiary-level neonatal intensive care unit (NICU). Data will be collected over a 1-year period, in which each NICU will collect data for 6 weeks. Data will be collected from the hospital’s written or electronic patient record files, recorded imaging reports, hospital blood bank records, and nurses’ records.
Interventions
- OTHER: In this international, multicenter, prospective, observational point prevalence study, the researchers will include neonates with gestational age at birth <32 weeks admitted to a participating tertiary-level neonatal intensive care unit (NICU). Data will be collected over a 1-year period, in which each NICU will collect data for 6 weeks. Data will be collected from the hospital’s written or electronic patient record files, recorded imaging reports, hospital blood bank records, and nurses’ record
Inclusion criteria
A potential subject who meets both of the following criteria can be included in this study:
1. Admission to a participating tertiary level NICU during the study period (note: this also includes neonates who are admitted to the NICU prior to the start of the study period, born outside the NICU institute of admission and/or readmitted to the NICU)
2. Gestational age at birth below 32 weeks (note: the postmenstrual age [PMA; gestational age + chronological age] at admission can be ≥32+0 weeks, however the PMA at inclusion cannot exceed 44+0 weeks)
Exclusion criteria
Does not meet the inclusion criteria
Locations
- , , Austria
- , , Poland
- , , Spain
- , , Italy
- , , Croatia
- , , Netherlands
- , , Switzerland
- , , Portugal
- , , Hungary
- , , Romania
- , , Germany
- , , Slovenia
- , , Slovakia
- , , Ireland
- , , Denmark
- , , Sweden
- , , Czech Republic
- , , France
- , , Norway
- , , Bosnia and Herzegovina
Related clinical trials
View on source registry